Cargando…

Assessment of the availability of repurposed orphan drugs in India

India has a massive burden of rare diseases (RDs), with an estimated 96 million people living with RDs but limited options for treatment. Repurposing drugs used for other common conditions are essential alternative for RDs due to their cost-effectiveness and reduced timeline. India’s patent regime p...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajueni, Khujith, Chakraborty Choudhury, Mohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10529578/
https://www.ncbi.nlm.nih.gov/pubmed/37756282
http://dx.doi.org/10.1371/journal.pgph.0001498